Crinetics Pharmaceuticals Inc. (CRNX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
5:22 pm
Sale
2021-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
Vivo Capital VIII, LLC0
0.000%
-1,819,600decrease
(Position Closed)
Filing
History
2022-02-11
4:19 pm
Purchase
2021-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
ORBIMED ADVISORS LLC3,196,876
6.700%
443,309increase
(+16.10%)
Filing
History
2022-02-10
8:21 pm
Sale
2021-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
Versant Venture Capital V, L.P.382,961
0.800%
-1,512,041decrease
(-79.79%)
Filing
History
2022-02-10
4:30 pm
Purchase
2021-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
Struthers Richard Scott1,978,334
4.200%
274,339increase
(+16.10%)
Filing
History
2022-02-03
4:41 pm
Purchase
2021-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
BlackRock Inc.
BLK
3,276,170
6.900%
1,162,975increase
(+55.03%)
Filing
History
2022-01-10
1:26 pm
Sale
2022-01-0713GCrinetics Pharmaceuticals, Inc.
CRNX
FMR LLC3,722,294
7.836%
-1,216,055decrease
(-24.62%)
Filing
History
2022-01-10
11:09 am
Purchase
2021-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
DRIEHAUS CAPITAL MANAGEMENT LLC4,793,638
10.090%
4,793,638increase
(New Position)
Filing
History
2021-10-29
4:29 pm
Purchase
2021-10-2113GCrinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P3,003,879
6.500%
3,003,879increase
(New Position)
Filing
History
2021-04-22
5:56 pm
Purchase
2021-04-1913GCrinetics Pharmaceuticals, Inc.
CRNX
Deep Track Capital, LP1,898,666
5.050%
1,898,666increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2